Trial overview
Aggregated metrics across all sponsored trials. Updated every 4 hours.
Active trials
3
+1 this quarter
Total participants
847
Across all trials
Active participants
621
73% retention rate
Completed cases
1,284
All time
Pending consents
18
Requires attention
Protocol deviations
2
Under review
Trial status summary
TRIAL-2024-001 — Phase II Cardio Study
68%
Recruiting
TRIAL-2024-002 — Oncology Biomarker
91%
Follow-up
TRIAL-2024-003 — Rare Disease Registry
24%
Screening
Participant-level data is de-identified in accordance with ICH E6(R2) Good Clinical Practice guidelines. This view shows aggregated statistics only. Contact your site administrator for detailed reports.